Emergent BioSolutions (EBS) Tops Q4 EPS by 19c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.55 --0%
Revenue Growth %: -45.6%
Financial Fact:
Interest expense: -2.05M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -45.6%
Financial Fact:
Interest expense: -2.05M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q4 EPS of $0.67, $0.19 better than the analyst estimate of $0.48. Revenue for the quarter came in at $151.7 million versus the consensus estimate of $120.45 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- Ennis (EBF) Misses Q2 EPS by 2c
- CRH plc (CRH) PT Lowered to $135 at UBS, Buy Rating Maintained
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
